Virology

TWiV 163: What Rous wrought

Hosts: Vincent Racaniello, Dickson Despommier, Rich Condit, and Alan Dove Vincent, Dickson, Rich, and Alan review the 100 year old finding by Peyton Rous of a transmissible sarcoma of chickens, a discovery that ushered in the era of tumor virology. Please help us by taking our listener survey. [powerpress url="http://traffic.libsyn.com/twiv/TWiV163.mp3"] Click the ...

Science retracts paper on detection of XMRV in CFS patients

Bruce Alberts, Editor-in-Chief of Science magazine, writes that the journal is retracting the 2009 paper describing the detection of the retrovirus XMRV in patients with chronic fatigue syndrome: Science is fully retracting the Report "Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome". He ...

A bad day for science

The virologists who carried out the contentious experiments on influenza H5N1 transmission in ferrets have agreed to remove certain details from their manuscript, according to ScienceInsider: Two groups of scientists who carried out highly controversial studies with the avian influenza virus H5N1 have reluctantly agreed to strike certain details from ...

TWiV 162: Transcription

Hosts: Vincent Racaniello, Rich Condit, and Alan Dove Vincent, Rich, and Alan continue Virology 101 with a discussion of transcription, the process of making mRNA from a DNA template. Please help us by taking our listener survey. [powerpress url="http://traffic.libsyn.com/twiv/TWiV162.mp3"] Click the arrow above to play, or right-click to download TWiV 162 ...

A $707 million investment in cell-based influenza vaccine

The United States has provided a large sum of money to pharmaceutical giant Novartis to produce influenza vaccines grown in cell culture. According to CIDRAP: Novartis's US efforts have been spurred by two major federal contracts. In 2006 the firm won a $220 million HHS contract to develop cell-based flu ...
Scroll to Top